Morepen Laboratories Limited logo

MOREPENLAB

NSE
Morepen Laboratories Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
50.12
2.83 (5.98%)
High VOLATILITY
As on 12 Jun 2026

Price History

Market Cap
₹2.75K Cr
SMALL CAP
P/E Ratio
27.1
Industry
Pharmaceuticals
52-Week Range
52W Low33.05+51.6%
52W High70.5-28.9%
Current Price
50.12
Circuit Limits (20%)
Lower Circuit40.10
Upper Circuit60.14
Reference Price
50.12

Investment Checklist

Inverse Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹54.31
Double Bottom on 1D (BREAKOUT CONFIRMED) — target ₹59.87
Trend: Price above all key MAs — strong uptrend
Golden Cross detected 1 day(s) ago
Composite score 42.71 (BUY) with 53.5% confidence

Technical Analysis

Technical Analysis

Analysis from 2026-06-12

Confidence
54%

Trend

BULLISH
BULLISH

Price above all key MAs — strong uptrend

EMA20
45.36
EMA50
43.32
EMA200
45.37

Price Action

MIXED
NEUTRAL
Higher Highs4
Higher Lows5
Lower Highs5
Lower Lows4

Support & Resistance Levels

Resistance (Above)
50.38
51.10
55.50
59.71
65.12
Support (Below)
49.62
48.84
47.64
47.00
46.31

Volume Analysis

TrendINCREASING
Change+368.20%
Unusual VolumeNo

Recent MA Crossovers

Golden Cross
1 day ago
BUY

Stop Loss Levels

Fixed Risk

1% Risk49.62
3% Risk48.62
5% Risk47.61
7% Risk (Custom)
46.61

Technical Levels

1x ATR (Volatility)47.41
2x ATR (Swing)44.70
3x ATR (Trend)41.99
Immediate Support49.62

Moving Averages

EMA 9 (Short-term)46.93
EMA 20 (Medium-term)45.36
EMA 50 (Trend)43.32
EMA 200 (Long-term)45.37

Financials

Financial Analysis

MetricMar '25Jun '25Sep '25Dec '25
Revenue₹458 Cr₹425.2 Cr₹411.6 Cr₹484.2 Cr
Net Profit₹20.3 Cr₹10.7 Cr₹40.9 Cr₹27.5 Cr
EPS₹0.20₹0.75₹0.50
Operating Profit₹46.3 Cr₹28.6 Cr₹61.2 Cr₹50.1 Cr
ROE
10.21%
ROCE
12.91%
Debt/Equity
0.09
Current Ratio
2.32
OPM
10.35%
NPM
5.68%

Peer Comparison

Pharmaceuticals

Peer Comparison

SymbolNamePriceChange
SUNPHARMASun Pharmaceutical Industries Limited₹1,807.70+0.75%
DIVISLABDivi's Laboratories Limited₹6,638.00-0.26%
TORNTPHARMTorrent Pharmaceuticals Limited₹4,571.20-0.02%
CIPLACipla Limited₹1,389.40+0.44%
ZYDUSLIFEZydus Lifesciences Limited₹1,104.70-0.11%
DRREDDYDr. Reddy's Laboratories Limited₹1,275.40-0.05%
LUPINLupin Limited₹2,293.30+0.88%
MANKINDMankind Pharma Limited₹2,381.10+0.35%
AUROPHARMAAurobindo Pharma Limited₹1,472.80+0.59%
LAURUSLABSLaurus Labs Limited₹1,394.30+0.25%

Corporate Information

Large Deals

View All

Bulk, Block and Short deals reported for this stock.

Loading Deals...

Corporate Actions

Recent actions

View All
Ex DatePurposeType
29 Aug 2025
Dividend - Re 0.20 Per Share
DIVIDEND
20 Sept 2024
Annual General Meeting
AGM
21 Sept 2023
Annual General Meeting
AGM
19 Sept 2022
Annual General Meeting
AGM
20 Sept 2021
Annual General Meeting
AGM

Announcements

Latest updates

View All
DateDescriptionLink
10 Jun 2026
Spurt in Volume
09 Jun 2026
Spurt in Volume
-
05 Jun 2026
Disclosure under SEBI Takeover Regulations
27 May 2026
Copy of Newspaper Publication
27 May 2026
Investor Presentation

Board Meetings

Upcoming and past meetings

View All
DatePurposeLinks
26 May 2026
Financial Results/Dividend/Other business matters
26 May 2026
Board Meeting Intimation
22 May 2026
Board Meeting Intimation
10 Feb 2026
Board Meeting Intimation
10 Feb 2026
Financial Results/Other business matters

Corporate Events

Upcoming results & meetings

View All

No upcoming events found

We couldn't find any scheduled corporate actions for this symbol at the moment.

Shareholding Pattern

Shareholding Pattern

As of Dec 2025

Current Distribution

Trend (Last 8 Qtrs)

Latest News

News for MOREPENLAB

View All
Buy or sell: Gift Nifty trades flat, Vaishali Parekh recommends three stocks to buy today — 27 May 2026
positive
LiveMint - Markets 17d ago

Buy or sell: Gift Nifty trades flat, Vaishali Parekh recommends three stocks to buy today — 27 May 2026

Buy or sell: Vaishali Parekh recommends three stocks to buy today — Morepen Laboratories, Radico Khaitan, and AU Small Finance Bank

ABSLBANETFAUBANKAXISBNKETFAXISBPSETFBANKADDBANKBEESBANKBETABANKBETFBANKETFBANKIETFBANKINDIABANKNIFTY1BANKPSUBBNPNBETFCAPITALSFBEBANKNIFTYEQUITASBNKESAFSFBFINIETFGROWWPSUBKHDFCNIFBANHDFCPSUBKHDFCPVTBANJSFBKHAITANLTDLTFMOREPENLABNPBETPSUBANKPSUBANKADDPSUBNKBEESPSUBNKIETFPVTBANIETFPVTBANKADDRADICOSDL26BEESSETFNIFBKSURYODAYUJJIVANSFBUTKARSHBNKVAISHALIConsumer DurablesFast Moving Consumer Goods
Morepen Laboratories Q4 net profit tanks despite higher revenue; declares ₹0.20 dividend
positive
CNBC TV18 - Markets 18d ago

Morepen Laboratories Q4 net profit tanks despite higher revenue; declares ₹0.20 dividend

Shares of Morepen Laboratories Ltd ended at ₹44.10, up by ₹0.36, or 0.82%, on the BSE.

BSEDIVIDENDMOREPENLABFinancial ServicesHealthcare

Frequently Asked Questions